研報掘金丨財信證券:維力醫療盈利能力持續提升,維持“增持”評級
財信證券研報指出,維力醫療業績穩步增長,盈利能力持續提升。近年來公司不斷鞏固導尿領域龍頭地位,推出一系列差異化產品,新增海外客戶測溫導尿管、硅膠導尿管等定製化業務,同時通過中標區域集採,進一步強化國內市場滲透,帶動導尿產品實現較快增長,2025H1公司導尿產品收入爲2.2億元,同比增長13.6%。公司通過穩健的經營策略、持續的研發投入和產品創新,以及積極的市場拓展,實現了業績的穩健增長,後續公司有望通過產品結構升級、新品上市入院、海外客戶持續拓展,保持業績持續增長。維持“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.